Table 2.
Nav channel | Lymph node metastasis CRC | Non-lymph node metastasis CRC | T | P |
---|---|---|---|---|
Nav 1.1 | 3.19 ± 2.91 | 2.05 ± 1.96 | 2.304 | 0.023 |
Nav 1.2 | 2.07 ± 2.37 | 1.97 ± 1.96 | 0.213 | 0.832 |
Nav 1.3 | 0.34 ± 0.45 | 0.41 ± 0.52 | − 0.682 | 0.497 |
Nav 1.4 | 3.08 ± 2.90 | 2.23 ± 2.21 | 1.630 | 0.106 |
Nav 1.5 | 1.64 ± 1.34 | 1.17 ± 1.186 | 1.811 | 0.073 |
Nav 1.6 | 3.63 ± 3.21 | 2.13 ± 1.96 | 2.534 | 0.014 |
Nav 1.7 | 1.80 ± 1.76 | 2.13 ± 2.48 | − 0.683 | 0.496 |
Nav 1.8 | 3.11 ± 2.72 | 2.59 ± 1.94 | 1.098 | 0.275 |
Nav 1.9 | 1.66 ± 1.48 | 1.86 ± 1.70 | − 0.603 | 0.548 |
The independent sample t test in SPSS20.0 was used to determine whether lymph node metastasis was a grouping variable, and the expression of the sodium ion channel subtype was a test variable. When the sig value of the Levene test is greater than 0.05, the T value and the P value are obtained by assuming the variance is equal. When the sig value of the Levene test is less than 0.05, the T value and the P value are obtained by assuming that the variances are not equal. An obtained P value < 0.05 is indicated in italic